Work

Efficacy and Safety of Voxelotor in Adolescents and Adults with Sickle Cell Disease: HOPE Trial 72-Week Analysis

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-140553

Authors: Jo Howard, Kenneth I. Ataga, R. Clark Brown, Maureen Achebe, Videlis Nduba, Amal El-Beshlawy, Hoda Hassab, Irene Agodoa, Margaret Tonda, Sarah Gray, Joshua Lehrer-Graiwer, Elliott Vichinsky

Institutions: Guy's and St Thomas' NHS Foundation Trust, University of Tennessee Health Science Center, Emory University, Children's Healthcare of Atlanta, Brigham and Women's Hospital, Harvard University, Kenya Medical Research Institute, Cairo University, Alexandria University, Global Blood Therapeutics (United States), UCSF Benioff Children's Hospital

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097390986

Cites:

Cited by: 4

Related to: 10